Get updates on COVID-19 research at COVID-19 Resource
Crop Biotech Update

BioServe Develops PCR-Based GMO Screening Tests

July 30, 2010

BioServe, a provider of genomic solutions and services to the biotech industry, has a line of new molecular PCR tests for the detection of any and all commercialized genetically modified organisms (GMOs) to a 0.1% limit of detection of the substance tested. Rama Modali, President of BioServe, says that "These tests for GMOs are the first of what will be a comprehensive portfolio of molecular tests for pathogens and healthcare diagnostics."

The company's laboratories in India have likewise received accreditation from the National Board of Testing and Calibration of Laboratories (NABL) for the detection of GM materials in raw and processed foods.

For more information visit http://www.bioserve.com